Counter views welcome Phlipper. Any delaying effect on the trials due to the virus will be one of risk assessment. Many factors will come into play, obviously dominated by the spread of the virus in the US and the general policy framework implemented to combat this.
ACADIA's main preoccupation here will be the assessment of risks to the girls and protection of the integrity of the trials, which of course will be multifaceted. I am sure top level discussions in this regard are already well underway.
This unfortunate event is going to effect many of the processes which govern everyday lives and, IMO, to think that our trial will come out unscathed is rather naive. I guess, that at this stage, the degree of any disruption is still speculation.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)